Marken acquires three European firms, assessing additional deals: ‘Stay tuned,’ says CEO

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Shutter_m)
(Image: Getty/Shutter_m)

Related tags: Marken, Logistics, Europe, Clinical development

Marken has purchased three European logistics firms and is assessing additional locations at which the CEO said it plans to either build or buy.

Marken’s acquisition of Italy-based HRTL as well as HETO and Der Kurier in Austria and Hungary, respectively, increases the company’s site network to 51, including 10 good manufacturing practice (GMP) qualified clinical storage depots. 

Marken CEO Wes Wheeler said the acquisitions make “good business sense”​ for the company given the large number of shipments exported from Italy, Hungary, and Austria. “Italy is a particularly important market for outbound services given the high concentration of sterile drugs produced in that country,”​ he told us.

Marken will offer its hybrid services​ – which uses UPS' network and airline – to and from gateway airports in Rome, Milan, Vienna, and Budapest.

The acquisition will see the addition of 30 new employees dedicated to clinical logistics. This also will further expand Marken’s direct to/from patient operations to these countries, giving the company more direct control of the drivers calling on patient’s homes. 

As for future acquisition plans, Wheeler said the company is “always looking to strengthen its network around the world.”

“We analyze data sources to determine where the patients are being recruited from and then assess if it makes good business sense to have a direct operation there,” ​he explained.

Marken is currently in the process of assessing an additional three to four locations at which it plans to either build or buy. Said Wheeler, “Stay tuned for further announcements.”

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars